AUA: Vesicoureteral Reflux (2017): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 79: | Line 79: | ||
=== Goals of management (3): === | === Goals of management (3): === | ||
# '''Prevent recurring febrile UTIs''' | # '''<span style="color:#ff0000">Prevent recurring febrile UTIs''' | ||
#* '''While resolution of VUR will reduce the incidence of febrile UTI/pyelonephritis''', '''the overall incidence of UTI may remain unchanged''' | #* '''While resolution of VUR will reduce the incidence of febrile UTI/pyelonephritis''', '''the overall incidence of UTI may remain unchanged''' | ||
# '''Prevent renal injury''' | # '''<span style="color:#ff0000">Prevent renal injury''' | ||
#* '''In the setting of acute pyelonephritis, VUR significantly increases the risk of developing renal scarring''' | #* '''In the setting of acute pyelonephritis, VUR significantly increases the risk of developing renal scarring''' | ||
# '''Minimize the morbidity of treatment and follow-up''' | # '''<span style="color:#ff0000">Minimize the morbidity of treatment and follow-up''' | ||
=== '''Antibiotic prophylaxis''' === | === '''Antibiotic prophylaxis''' === | ||
* '''RIVUR''' | * '''<span style="color:#ff00ff">RIVUR''' | ||
** '''Population: 607 children with''' dilated and non-dilated '''VUR that was diagnosed after''' a first or second '''febrile or symptomatic UTI''' | ** '''Population: 607 children with''' dilated and non-dilated '''VUR that was diagnosed after''' a first or second '''febrile or symptomatic UTI''' | ||
*** Population was overwhelmingly female (91%) | *** Population was overwhelmingly female (91%) | ||